Table 1 Characteristics of the study population (Group 2) at the baseline (months 7–8) of the second phase of the trial
Complete diaries (N = 162) | Incomplete diaries (N = 15) | p | Total (n = 177) | |
|---|---|---|---|---|
Age, median (IQ range) | 44.0 (35;49) | 45.0 (34.5;54.5) | 0.549 | 44 (35–49) |
Females | 138 (85.2%) | 11 (73.3%) | 149 (84.2%) | |
Migraine with or without aura (M)a, without TTH | 53 (32.7%) | 4 (26.7%) | 0.777 | 57 (32.2%) |
Tension type headache (TTH)a, without M | 41 (25.3%) | 5 (33.3%) | 0.343 | 46 (26.0%) |
Migraine and TTH | 37 (22.8%) | 3 (20.0%) | 0.548 | 40 (22.6%) |
Myogenous neck and shoulder pain (MP)a | 124 (76.5%) | 12 (80.0%) | 0.761 | 136 (76.8%) |
M or TTH, without MP | 23 (14.20%) | 1 (6.67%) | 0.580 | 24 (13.6%) |
MP, without M or TTH | 16 (9.88%) | 1 (6.67%) | 0.565 | 17 (9.6%) |
M or TTH, and MP | 108 (66.7%) | 11 (73.3%) | 0.599 | 119 (67.2%) |
Subjects with at least 4 days/monthb with: | ||||
Headache | 73 (45.1%) | 9 (60.0%) | 0.267 | 82 (46.3%) |
Neck or shoulder pain | 69 (42.6%) | 9 (60.0%) | 0.194 | 78 (44.1%) |
Consumption of analgesic drugs | 24 (14.8%) | 3 (20.0%) | 0.705 | 27 (15.3%) |
GAD and/or Depression (at month 8) | 49 (30.2%) | 7 (46.7%) | 0.191 | 56 (31.6%) |